Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-03-12 | Y-mAbs Therapeutics, Inc. | TAGLIAFERRI MARY
(Director) |
A | Common Stock | A | 4660 | $0.00 - $0.00 | $0 |
| 2024-01-18 | Y-mAbs Therapeutics, Inc. | Rajah Vignesh
(SVP & CHIEF MEDICAL OFFICER) |
A | Common Stock | A | 17800 | $0.00 - $0.00 | $0 |
| 2024-01-18 | Y-mAbs Therapeutics, Inc. | Lisby Steen
(SVP & CHIEF SCIENTIFIC OFFICER) |
A | Common Stock | A | 17800 | $0.00 - $0.00 | $0 |
| 2024-01-18 | Y-mAbs Therapeutics, Inc. | Wilms Joris
(SVP & CHIEF OPERATING OFFICER) |
A | Common Stock | A | 17800 | $0.00 - $0.00 | $0 |
| 2024-01-18 | Y-mAbs Therapeutics, Inc. | Lund-Hansen Torben
(SVP & CHIEF TECHNICAL OFFICER) |
A | Common Stock | A | 17800 | $0.00 - $0.00 | $0 |
| 2024-01-18 | Y-mAbs Therapeutics, Inc. | Gad Thomas
(CHIEF BUSINESS OFFICER) |
A | Common Stock | A | 22100 | $0.00 - $0.00 | $0 |
| 2024-01-18 | Y-mAbs Therapeutics, Inc. | Kruse Bo
(EVP, CFO, SECRY & TREAS.) |
A | Common Stock | A | 18100 | $0.00 - $0.00 | $0 |
| 2023-12-13 | Y-mAbs Therapeutics, Inc. | Gad Thomas
(Chief Business Officer) |
S | Common Stock | D | 150000 | $6.58 - $6.83 | $1,001,000 |
| 2023-11-29 | Y-mAbs Therapeutics, Inc. | Wedell-Wedellsbor...
(Director) |
P | Common Stock | A | 51837 | $5.97 - $5.97 | $309,477 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |